Louis G. Lange, Director at Audentes Therapeutics, Inc. (BOLD), sold 44,000 shares at $22.49 ($990K) on 2018-11-15, disclosed to the SEC on 2018-11-16.
Open-market sale of $990k BOLD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.49 | 4,000 | $90K | 9.1% |
| 2 | $22.49 | 20,000 | $450K | 45.5% |
| 3 | $22.49 | 20,000 | $450K | 45.5% |
| Total | $22.49 avg | 44,000 | $990K | 100% |
| Filing → |
| NAMS | BUY | 2024-02-21 | $95K | — | Filing → |
| BOLD | SELL | 2019-12-27 | $656K | — | Filing → |
| BOLD | SELL | 2019-09-25 | $667K | — | Filing → |